← FDA Drug Approvals (Drugs@FDA)

BREO ELLIPTA

NDA · New Drug Application · Sponsor: GLAXO GRP LTD · Approved 2013-05-10

Drug application

FDA Application #

NDA204275

Application type

New Drug Application

Brand name

BREO ELLIPTA

Generic name

FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE

Active ingredients

FLUTICASONE FUROATE; VILANTEROL TRIFENATATE

Dosage form

POWDER

Route

INHALATION

Marketing status

Prescription

Sponsor

GLAXO GRP LTD

Manufacturer

GlaxoSmithKline LLC

First approval

2013-05-10

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown